Nigel Garrett

Best Publications

• Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

  Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  809
  Citations

• Genital Inflammation and the Risk of HIV Acquisition in Women

  Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  459
  Citations

• Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

  Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  346
  Citations

• The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.

  Jienchi Dorward;Jienchi Dorward;Thokozani Khubone;Kelly Gate;Hope Ngobese

  295
  Citations

• New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

  Nicole A. Doria-Rose;Jinal N. Bhiman;Jinal N. Bhiman;Ryan S. Roark;Chaim A. Schramm

  273
  Citations

• Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

  Jinal N. Bhiman;Jinal N. Bhiman;Colin. Anthony;Nicole A. Doria-Rose;Owen. Karimanzira

  239
  Citations

• Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

  Glenda E. Gray;Glenda E. Gray;Glenda E. Gray;Linda Gail Bekker;Fatima Laher;Mookho Malahleha

  214
  Citations

• The Replication-Competent HIV-1 Latent Reservoir is Primarily Established Near the Time of Therapy Initiation

  Melissa-Rose Abrahams;Sarah B. Joseph;Nigel Garrett;Lynn Tyers

  210
  Citations

• Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression

  Henrik N. Kløverpris;Henrik N. Kløverpris;Samuel W. Kazer;Jenny Mjösberg;Jenniffer M. Mabuka

  165
  Citations

• Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa

  Unknown

  156
  Citations

• Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

  Unknown

  139
  Citations

• Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries

  Nigel Joel. Garrett;Nigel Joel. Garrett;Farzana. Osman;Bhavna. Maharaj;Nivashnee. Naicker

  134
  Citations

• Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei.

  Magdalena J. Koziol;Magdalena J. Koziol;Nigel Garrett;Nigel Garrett;J.B. Gurdon;J.B. Gurdon

  125
  Citations

• Case report: mechanisms of HIV elite control in two African women.

  Yumna. Moosa;Ramla F. Tanko;Veron. Ramsuran;Veron. Ramsuran;Veron. Ramsuran;Ravesh. Singh

  119
  Citations

• Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.

  Jienchi. Dorward;Richard John. Lessells;Paul K. Drain;Kogieleum. Naidoo;Kogieleum. Naidoo

  118
  Citations

• Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

  Ian Setliff;Wyatt J. McDonnell;Nagarajan Raju;Robin G. Bombardi

  115
  Citations

• Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

  Paul K. Drain;Jienchi Dorward;Jienchi Dorward;Andrew Bender;Lorraine Lillis

  114
  Citations

• Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes

  Aida Sivro;Aida Sivro;Alexandra Schuetz;Daniel Sheward;Vineet Joag

  109
  Citations

• Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.

  Roanne Keeton;Simone I. Richardson;Simone I. Richardson;Thandeka Moyo-Gwete;Thandeka Moyo-Gwete;Tandile Hermanus;Tandile Hermanus

  108
  Citations

• Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial

  Paul K Drain;Jienchi Dorward;Jienchi Dorward;Lauren R Violette;Justice Quame-Amaglo

  105
  Citations